Unknown

Dataset Information

Advanced liver fibrosis, but not MASLD, is associated with accelerated biological aging: a population-based study.


ABSTRACT:

Background

The process of biological aging in patients diagnosed with chronic liver disease remains unclear.

Aim

The current study aims to investigate if there is an accelerated biological aging process in participants with advanced fibrosis (AF) and metabolic dysfunction-associated steatotic liver disease (MASLD).

Methods

Data from the 2017-2018 NHANES cycle were analyzed. AF was determined based on the values of liver stiffness measurement (LSM) and MASLD was defined according to new consensus nomenclature. Klemera-Doubal method biological age (KDM bioage) and Phenotypic age (Phenoage) were adopted to quantify biological age. Phenoage advancement (Phenoage_advance) and KDM advancement (KDM_advance) were generated as the difference between the calculated biological a

SUBMITTER: Tong C 

PROVIDER: S-EPMC11600614 | biostudies-literature | 2024 Nov

REPOSITORIES: biostudies-literature